Citron Launches ‘Rise by Citron’ – Opening Its Full Infrastructure to Homegrown GCC Brands
Dubai, 24 March 2026 Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Wegovy® HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess body weight and maintain weight reduction long-term. The FDA awarded Read More



